VIA
AKRO

Virtus Investment Advisers’s Akero Therapeutics AKRO Stock Holding History

Virtus Investment Advisers’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,125
Closed -$101K – 463
2025
Q3 		$101K Buy
2,125
+369
+21% +$17.9K 0.03% 424
2025
Q2 		$93.7K Sell
1,756
-3,898
-69% -$177K 0.03% 359
2025
Q1 		$229K Buy
+5,654
New +$240K 0.06% 255

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Virtus Investment Advisers's AKRO Position: Q4 2025 in Review

Virtus Investment Advisers sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 2,125 shares — an estimated $101K sold.

Virtus Investment Advisers first reported a position in AKRO in Q1 2025 and held it in 3 quarters. The position peaked at $229K in Q1 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Virtus Investment Advisers reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 2,125 Akero Therapeutics shares in Q4 2025, an estimated $101K.
  • Virtus Investment Advisers first reported a position in Akero Therapeutics in Q1 2025 and held it in 3 quarters.
  • Virtus Investment Advisers's Akero Therapeutics position peaked at $229K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Virtus Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.